CD31/PECAM automated and quantitative immunocytochemical assays in breast carcinomas: Correlation with patient follow-up

American Journal of Clinical Pathology

Volumn 107, Issue 5, 1997, Pages 534-541

  Charpin, Colette ^a,b   Garcia, Stéphane ^b   Bouvier, Corinne ^b   Martini, François ^b   Andrac, Lucile ^a   Bonnier, Pascal ^b   Lavaut, Marie Noëlle ^a   Allasia, Claude ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

^b HÔPITAL NORD   (France)

Author keywords

Automated immunoperoxidase; Breast carcinoma; CD31; Image analysis; Immunocytochemistry; Microvessel density; Patient survival

Indexed keywords

CD31 ANTIGEN;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CARCINOMA; CANCER SIZE; COMPUTER ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; FROZEN SECTION; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOCYTOCHEMISTRY; LABORATORY AUTOMATION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ASSAY; SURVIVAL RATE;

EID: 0030935524     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/107.5.534     Document Type: Article

References (37)

1. McGuire WL, Clark G. Prognostic factors and treatment decisions in axillary-node-negative breast cancer. N Engl J Med. 1992;326:1756-1760.
2. Liotta LA, Kleinerman J, Saidel GM. Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation. Cancer Res. 1974;34:997-1004.
3. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med. 1971;285:1182-1186.
4. Gasparini G, Harris AL. Clinical importance of the determination of tumor angiogenesis in breast carcinoma: much more than a new prognostic tool. J Clin Oncol. 1995;13:765-782.
5. Weidner N, Semple JP, Welch WR, et al. Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. N Engl J Med. 1991;324:1-8.
6. Horak ER, Leek R, Klenk N, et al. Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet. 1992;340:1120-1124.
7. Siitonen SM, Haapasalo HK, Rantala IS, et al. Comparison of different immunohistochemical methods in the assessment of angiogenesis: lack of prognostic value in a group of 77 selected node-negative breast carcinomas. Mod Pathol. 1995;8:745-752.
8. Weidner N, Folkman J, Pozza F, et al. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst. 1992;84:1875-1887.
9. Bosari S, Lee AKC, DeLellis RA, et al. Microvessel quantitation and prognosis in invasive breast carcinoma. Hum Pathol. 1992;23:755-761.
10. Toi M, Kashitani J, Tominaga T. Tumor angiogenesis is an independent prognostic indicator in primary breast carcinoma. Int J Cancer. 1993;55:371-374.
11. Visscher DW, Smilanetz S, Drozdowicz S, et al. Prognostic significance of image morphometric microvessel enumeration in breast carcinoma. Anal Quant Cytol Histol. 1993;15:88-92.
12. Gasparini G, Weidner N, Bevilacqua P, et al. Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma. J Clin Oncol. 1994;12:454-466.
13. Fox SB, Leek RD, Weekes MP, et al. Quantitation and prognostic value of breast cancer angiogenesis: comparison of microvessel density, chalkley count, and computer image analysis. J Pathol. 1995;177:275-283.
14. Vermeulen PB, Libura J, Libura M, et al. J Natl Cancer Inst. 1995;87:1797-1798.
15. Barbareschi M, Gasparini G, Morelli L, et al. Novel methods for the determination of the angiogenic activity of human tumors. Breast Cancer Res Treat. 1995;36:181-192.
16. Bevilacqua P, Barbareschi M, Verderio P, et al. Prognostic value of intratumoral microvessel density, a measure of tumor angiogenesis, in node-negative breast carcinoma: results of a multi-parametric study. Breast Cancer Res Treat. 1995;36:205-217.
17. Hall NR, Fish DE, Hunt N, et al. Is the relationship between angiogenesis and metastasis in breast cancer real? Surg Oncol. 1992;1:223-229.
18. Van Hoef MEHM, Know WF, Dhesi SS, et al. Assessment of tumour vascularity as a prognostic factor in lymph node negative invasive breast cancer. Eur J Cancer. 1993;29A:1141-1145.
19. Axelsson K, Ljung BME, Moore DH II, et al. Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma. J Natl Cancer Inst. 1995;87:997-1008.
20. Goulding H, Nik Abdul Rashid NF, Robertson JF, et al. Assessment of angiogenesis in breast carcinoma: an important factor in prognosis? Hum Pathol. 1995;26:1196-1200.
21. Costello P, McCann A, Carney DN, et al. Prognostic significance of microvessel density in lymph node negative breast carcinoma. Hum Pathol 1995;26:1181-1184.
22. Fox SB, Gatter KC, Altman DG, et al. Tumor angiogenesis as a prognostic assay for invasive ductal carcinoma. J Natl Cancer Inst. 1995;87:1798. Correspondence.
23. Ellis LM, Fidler IJ. Angiogenesis and breast cancer metastasis. Lancet. 1995;346:388-389.
24. Charpin C, Devictor B, Bergeret D, et al. CD31 quantitative immunocytochemical assays in breast carcinomas: correlation with current prognostic factors. Am J Clin Pathol. 1995;103:443-448.
25. Grogan TM, Casey TT, Miller PC, et al. Automation of immunohistochemistry. Adv Pathol Lab Med. 1993;6:253-283.
26. Grogan TM, Rangel C, Rimsza L, et al. Kinetic-mode, automated double-labeled immunohistochemistry and in situ hybridization in diagnostic pathology. Adv Pathol Lab Med. 1995;8:79-99.
27. Galaktionov K, Lee AK, Eckstein J, et al. CDC25 phosphatases as potential human oncogenes. Science. 1995;269:1575-1577.
28. Santavicca M, Noel A, Chenard MP, et al. Characterization of monoclonal antibodies against stromelysin-3 and their use to evaluate stromelysin-3 levels in breast carcinoma by semiquantitative immunohistochemistry. Int J Cancer. 1995;64:336-341.
29. Santisteban MS, Brugal G. Image analysis of in situ cell cycle related changes of PCNA and Ki-67 proliferating antigen expression. Cell Prolif. 1994;27:435-453.
30. Esteban JM, Cul AHN, Mehta P, et al. Biologic significance of quantitative estrogen receptor immunohistochemical assay by image analysis in breast cancer. Am J Clin Pathol. 1994;102:158-162.
31. Charpin C, Andrac L, Vacheret H, et al. Multiparametric evaluation (SAMBA) of growth fraction (monoclonal Ki67) in breast carcinoma: a correlation of immunodetection in tissue sections and morphological data and estrogen and progesterone receptor immunocytochemical assays. Cancer Res. 1988;48:4368-4374.
32. Charpin C, Devictor B, Andrac L, et al. P-53 quantitative immunocytochemical analysis in breast carcinomas. Hum Pathol. 1995;26:159-166.
33. Charpin C, Vielh P, Duffaud F, et al. Quantitative immunocytochemical assays of P-glycoprotein in breast carcinomas: correlation to mRNA expression and to immunohistochemical prognostic indicators. J Natl Cancer Inst. 1994;20:1539-1545.
34. Altman DG, Lausen B, Sauerberi W, et al. Dangers of using "optimal" cutpoint in the evaluation of prognostic factors. J Natl Cancer Inst. 1994;86:829-835.
35. Weidner N. Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol. 1995;147:9-19.
36. Weidner N. Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid rumors. Breast Cancer Res Treat. 1995;36:169-180.
37. Wang JM, Kumar S, Pye D, et al. Breast carcinoma comparative study of tumor vasculature using two endothelial cell markers. J Natl Cancer Inst. 1995;86:386-388.